Multifunctional Chromatography Medium for Biologic Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current purification processes for protein therapeutics, particularly monoclonal antibodies, face challenges in effectively removing antibody fragments and aggregates due to the lack of robust chromatographic technology, leading to increased operational costs and complexity in downstream processing.
Innovation Solution
A multifunctional chromatography medium with defined pore diameter distribution and conjugated ligands is developed, allowing for the separation of target biologics from process- and product-related impurities in a single flow-through mode, utilizing silica beads or monoliths with specific pore sizes and ligands that bind impurities while allowing the biologic to flow through unbound.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If ion-exchange and hydrophobic interaction chromatography are used to remove antibody fragments and aggregates, then product purity is improved, but device complexity and operational costs increase due to multiple processing steps
Solution Approach 1:
The patent combines multiple chromatographic functions (ion-exchange, hydrophobic interaction, and size-exclusion) into a single mixed-mode chromatography medium. The porous beads contain both ion-exchange ligands and hydrophobic ligands, enabling simultaneous removal of antibody fragments and aggregates through one processing step rather than multiple sequential steps.
Solution Approach 2:
The chromatography medium is designed with universal applicability for removing different types of impurities (process-related and product-related) through multiple mechanisms. The same medium can operate in capture, polish, or continuous mode, and handles various impurity types including aggregates, fragments, and host cell proteins through its mixed-mode ligands.
2Manufacturing precision
If multiple chromatography steps are used to achieve high purity, then product purity is improved, but productivity decreases due to increased processing time and operational complexity
Solution Approach 1:
Multiple chromatographic separation functions are merged into a single medium that can remove both aggregates and fragments simultaneously. This eliminates the need for sequential processing steps, reducing total processing time while maintaining high purity levels through the combined action of ion-exchange and hydrophobic interaction mechanisms.
Solution Approach 2:
The medium enables continuous chromatography operations where the chromatography resin is continuously regenerated and reused. The system operates in a continuous flow-through mode with periodic regeneration, maintaining continuous productive action without interrupting the purification process, thereby increasing overall throughput.
3Ease of manufacture
If conventional chromatography media are used, then ease of manufacture is maintained, but manufacturing precision deteriorates due to inability to effectively remove antibody fragments
Solution Approach 1:
The chromatography medium uses composite porous beads that combine multiple ligand types (ion-exchange and hydrophobic ligands) within a single porous matrix. This composite structure enables the medium to address the technical challenge of fragment removal while maintaining compatibility with conventional chromatography manufacturing processes and operational procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution enables efficient removal of impurities, achieving high antibody yield and purity, with up to 80% yield and 97% monomeric purity, while reducing operational costs and simplifying the purification process by operating in continuous flow-through mode.
Implementation Method 1
the pore diameter distribution is configured to exclude a target biologic
Implementation Method 2
one or more ligands conjugated to the surface of the pores capable of capturing process-related impurities and product-related impurities
Data Source
AI summary
The present disclosure provides materials and methods related to the purification of a biologic. The present disclosure provides materials and methods related to the purification of a biologic. In particular, the present disclosure provides a multifunctional chromatography medium comprising porous beads or particles having a defined pore diameter distribution and one or more ligands conjugated to the surface of the pores capable of removing process-related impurities and product-related impurities from a target biologic.


